dipyridamole has been researched along with Fetal Growth Restriction in 15 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of low-dose aspirin in preventing fetal growth retardation was tested in a randomised, placebo-controlled, double-blind trial." | 9.07 | Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. ( Bazin, B; Beaufils, M; Breart, G; Capitant, C; Paris, J; Uzan, S, 1991) |
| "A multicentric randomized double-blind trial was realized in order to determine whether a treatment with a low-dose aspirin (150 mg/day) with or without dipyridamole (225 mg/day) was able to prevent the perinatal consequences of pre-eclampsia." | 9.07 | Prevention of perinatal consequences of pre-eclampsia with low-dose aspirin: results of the epreda trial. The Epreda Trial Study Group. ( Sureau, C, 1991) |
| " Low-dose aspirin and dipyridamole direct prostacyclin/thromboxane A2 balance in pregnancy to the dominance of prostacyclin and may thus prevent idiopathic uteroplacental insufficiency and fetal growth retardation in high-risk patients." | 9.06 | Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole. ( Rotmans, N; Wallenburg, HC, 1987) |
| "Quantitative sphygmometry was used to check the cardiovascular action of an intravenous injection of 30 mg of dipyridamole in ten women, between the 31st and 38th weeks of pregnancy." | 7.66 | [Cardiovascular action of dipyridamole in advanced pregnancy (author's transl)]. ( Lauckner, W; Retzke, U; Schwarz, R, 1981) |
| "The efficacy of low-dose aspirin in preventing fetal growth retardation was tested in a randomised, placebo-controlled, double-blind trial." | 5.07 | Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. ( Bazin, B; Beaufils, M; Breart, G; Capitant, C; Paris, J; Uzan, S, 1991) |
| "A multicentric randomized double-blind trial was realized in order to determine whether a treatment with a low-dose aspirin (150 mg/day) with or without dipyridamole (225 mg/day) was able to prevent the perinatal consequences of pre-eclampsia." | 5.07 | Prevention of perinatal consequences of pre-eclampsia with low-dose aspirin: results of the epreda trial. The Epreda Trial Study Group. ( Sureau, C, 1991) |
| " Low-dose aspirin and dipyridamole direct prostacyclin/thromboxane A2 balance in pregnancy to the dominance of prostacyclin and may thus prevent idiopathic uteroplacental insufficiency and fetal growth retardation in high-risk patients." | 5.06 | Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole. ( Rotmans, N; Wallenburg, HC, 1987) |
| "Quantitative sphygmometry was used to check the cardiovascular action of an intravenous injection of 30 mg of dipyridamole in ten women, between the 31st and 38th weeks of pregnancy." | 3.66 | [Cardiovascular action of dipyridamole in advanced pregnancy (author's transl)]. ( Lauckner, W; Retzke, U; Schwarz, R, 1981) |
| "The pregnancy was normal in 54% of patients in group A and 23% in group B (p less than 0." | 2.65 | [Controlled trial of preventive treatment of preeclampsia. Preliminary results]. ( Beaufils, M; Colau, JC; Donsimoni, R; Uzan, S, 1984) |
| "Aspirin (ASS) was the most frequently used drug in 47 of 93 recorded cases (51%)." | 2.39 | Essential thrombocythemia and pregnancy. ( Griesshammer, M; Heimpel, H; Pearson, TC, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (60.00) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beaufils, M | 5 |
| Uzan, S | 5 |
| Donsimoni, R | 2 |
| Colau, JC | 2 |
| van Wersch, JW | 1 |
| Zandvoort, JA | 1 |
| van Dieijen-Visser, MP | 1 |
| Lauckner, W | 1 |
| Schwarz, R | 1 |
| Retzke, U | 1 |
| Fursova, ZK | 1 |
| Balika, IuD | 1 |
| Mamedalieva, NM | 1 |
| Razumovskaia, IN | 1 |
| Griesshammer, M | 1 |
| Heimpel, H | 1 |
| Pearson, TC | 1 |
| Pollack, RN | 1 |
| Yaffe, H | 1 |
| Divon, MY | 1 |
| Bonnar, J | 1 |
| Redman, CW | 1 |
| Sheppard, BL | 1 |
| Bréart, G | 2 |
| Uzan, M | 1 |
| Paris, J | 2 |
| Bazin, B | 2 |
| Capitant, C | 1 |
| Sureau, C | 1 |
| Danays, T | 1 |
| Wallenburg, HC | 2 |
| Rotmans, N | 2 |
| Falconer, J | 1 |
| Pineo, G | 1 |
| Blahey, W | 1 |
| Bowen, T | 1 |
| Docksteader, B | 1 |
| Jadusingh, I | 1 |
2 reviews available for dipyridamole and Fetal Growth Restriction
| Article | Year |
|---|---|
Essential thrombocythemia and pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Aspirin; Busulfan; Combined Modality Therapy; Di | 1996 |
Therapy for intrauterine growth restriction: current options and future directions.
Topics: Adrenergic beta-Agonists; Aspirin; Atrial Natriuretic Factor; Bed Rest; Cyclooxygenase Inhibitors; D | 1997 |
7 trials available for dipyridamole and Fetal Growth Restriction
| Article | Year |
|---|---|
[Controlled trial of preventive treatment of preeclampsia. Preliminary results].
Topics: Adult; Aspirin; Blood Volume; Clinical Trials as Topic; Dipyridamole; Female; Fetal Growth Retardati | 1984 |
[Prevention of intrauterine growth retardation and pre-eclampsia by small doses of aspirin. Results of the french multicenter trial EPREDA and comparison with data in the literature; value of uterine Doppler].
Topics: Aspirin; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Fetal Growth Retardat | 1992 |
Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial.
Topics: Adult; Aspirin; Birth Weight; Dipyridamole; Double-Blind Method; Drug Administration Schedule; Drug | 1991 |
Prevention of perinatal consequences of pre-eclampsia with low-dose aspirin: results of the epreda trial. The Epreda Trial Study Group.
Topics: Abruptio Placentae; Aspirin; Birth Weight; Dipyridamole; Double-Blind Method; Drug Combinations; Fem | 1991 |
Idiopathic recurrent fetal growth retardation and aspirin-dipyridamole therapy.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Female; Fetal Growth Ret | 1989 |
Prospective controlled study of early antiplatelet therapy in prevention of preeclampsia.
Topics: Adult; Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Fetal Growth Retardation; Humans; Pa | 1986 |
Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole.
Topics: Adult; Aspirin; Birth Weight; Clinical Trials as Topic; Dipyridamole; Epoprostenol; Female; Fetal Gr | 1987 |
6 other studies available for dipyridamole and Fetal Growth Restriction
| Article | Year |
|---|---|
Heparin-dipyridamole (Persantin) treatment in pregnancy: effect on blood coagulation parameters.
Topics: Adolescent; Adult; Clot Retraction; Dipyridamole; Female; Fetal Growth Retardation; Fibrin Fibrinoge | 1983 |
[Cardiovascular action of dipyridamole in advanced pregnancy (author's transl)].
Topics: Adult; Dipyridamole; Female; Fetal Growth Retardation; Hemodynamics; Humans; Placental Insufficiency | 1981 |
[Characteristics of lymphocytic enzyme status of the newborn after metabolic therapy of pregnant women].
Topics: Abortion, Habitual; Benzenesulfonates; Dipyridamole; Estradiol Congeners; Female; Fetal Growth Retar | 1995 |
Treatment of fetal growth retardation in utero with heparin and dipyridamole.
Topics: Dipyridamole; Female; Fetal Growth Retardation; Heparin; Humans; Hypertension; Placenta; Placental F | 1975 |
Prophylactic low-dose aspirin and dipyridamole in pregnancy.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Fetal Death; Fetal Growth Retardation; Hum | 1988 |
Essential thrombocythemia associated with recurrent abortions and fetal growth retardation.
Topics: Abortion, Habitual; Adult; Aspirin; Dipyridamole; Female; Fetal Growth Retardation; Humans; Platelet | 1987 |